ConductScience.org, home

Paper279397

Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.

Legha SS and 6 others. Cancer Res, 1978. Cited by 129 papers, by iCite.

Cite this record

ConductScience Library. Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative. Papers, record 279397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/279397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.
PubMed
Journal
Cancer Res
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
129
iCite
Relative citation ratio, by iCite
5.59
iCite
Revised in PubMed
2007-11-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Legha SSS S
2Gutterman JUJ U
3Hall SWS W
4Benjamin RSR S
5Burgess MAM A
6Valdivieso MM
7Bodey GPG P

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcridinesMajor topic
NeoplasmsMajor topic
Adenocarcinoma
Adult
Aged
Antineoplastic Agents
Bone Marrow
Drug Administration Schedule
Drug Evaluation
Female
Humans
Injections, Intravenous
Leukemia, Myeloid, Acute
Lung Neoplasms
Male
Melanoma
Middle Aged
Phenylenediamines
Remission, Spontaneous

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
23922861Role of minor groove width and hydration pattern on amsacrine interaction with DNA.PLoS One2013https://conductscience.org/library/papers/23922861PubMed
10789823Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.Drug Saf2000https://conductscience.org/library/papers/10789823PubMed
7002528Cancer chemotherapy: new developments and changing concepts.Drugs1980https://conductscience.org/library/papers/7002528PubMed
6961970Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA).Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6961970PubMed
6895696A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.Br J Cancer1981https://conductscience.org/library/papers/6895696PubMed
6895486A phase II trial of m-AMSA in head and neck cancer.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/6895486PubMed
6895485A phase II study of m-AMSA in patients with primary liver cancer.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/6895485PubMed
6688382Influence of scheduling on therapeutic and toxic effect of AMSA in Lewis lung carcinoma.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6688382PubMed
6583026Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA).Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6583026PubMed
3621451Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3621451PubMed
3568274Amsacrine treatment of patients with supraventricular arrhythmias and acute leukemia.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3568274PubMed
3186443Cooperative binding of m-AMSA to nucleic acids.Nucleic Acids Res1988https://conductscience.org/library/papers/3186443PubMed
2602146Thermodynamics of the interactions of m-AMSA and o-AMSA with nucleic acids: influence of ionic strength and DNA base composition.Nucleic Acids Res1989https://conductscience.org/library/papers/2602146PubMed
393427m-AMSA and PALA: two new agents in cancer chemotherapy.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/393427PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/279397

GET https://conductscience.org/api/papers/v1/279397/authors